Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Cody

Showing results (51-60 of 114) with videos related to

Pageof 12
Sort By:
Acta Crystallographica. Section D, Biological Crystallography|July 27, 2001
Structure of rat transthyretin (rTTR) complex with thyroxine at 2.5 A resolution: first non-biased insight into thyroxine binding reveals different hormone orientation in two binding sitesA Wojtczak, V Cody, J R Luft, et al.
Molecular Endocrinology (Baltimore, Md.)|March 1, 1994
Computer-assisted molecular modeling of benzodiazepine and thyromimetic inhibitors of the HepG2 iodothyronine membrane transporterL Kragie, M L Forrester, V Cody, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 1, 1996
Structures of human transthyretin complexed with thyroxine at 2.0 A resolution and 3',5'-dinitro-N-acetyl-L-thyronine at 2.2 A resolutionA Wojtczak, V Cody, J R Luft, et al.
The Journal of Biological Chemistry|September 5, 1986
Inhibition of rat liver iodothyronine deiodinase. Interaction of aurones with the iodothyronine ligand-binding siteM Auf'mkolk, J Koehrle, R D Hesch, et al.
Progress in Clinical and Biological Research|January 1, 1986
Structure-activity relationships of flavonoid deiodinase inhibitors and enzyme active-site modelsV Cody, J Koehrle, M Auf'mkolk, et al.
Anti-Cancer Drug Design|October 1, 1993
Structural and conformational studies on bio-active flavonoids. Crystal and molecular structure of a complex formed between 2',6'-dimethoxyflavone and orthophosphoric acid: a model for flavone-nucleotide interactionsJ C Wallet, V Cody, A Wojtczak, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
Isolation of rat dihydrofolate reductase gene and characterization of recombinant enzymeY Wang, J A Bruenn, S F Queener, et al.
Journal of Medicinal Chemistry|December 1, 1977
Molecular structure of thyroxine analogues. Crystal structure of 3,5,3'-triiodothyroacetic and 3,5,3',5'-tetraoiodothyroacetic acid N-diethanolamine (1:1) complexesV Cody, J Hazel, D A Langs, et al.
Drug Design and Discovery|August 1, 1995
Dopaminergic (4aR,10bS)-cis- and (4aS,10bS)-trans-octahydrobenzo[F]quinolines have similar pharmacophoresM Froimowitz, Y Deng, J N Jacob, et al.
Journal of Sports Science & Medicine|April 30, 2014
The physiological responses of chronic heart failure patients to maximal strength test and a balke incremental testItamar Levinger, Roger Bronks, David V Cody, et al.
Pageof 12

Showing results (51-60 of 114) with videos related to

Sort By:
Pageof 12
Acta Crystallographica. Section D, Biological Crystallography|July 27, 2001
Structure of rat transthyretin (rTTR) complex with thyroxine at 2.5 A resolution: first non-biased insight into thyroxine binding reveals different hormone orientation in two binding sitesA Wojtczak, V Cody, J R Luft, et al.
Molecular Endocrinology (Baltimore, Md.)|March 1, 1994
Computer-assisted molecular modeling of benzodiazepine and thyromimetic inhibitors of the HepG2 iodothyronine membrane transporterL Kragie, M L Forrester, V Cody, et al.
Acta Crystallographica. Section D, Biological Crystallography|July 1, 1996
Structures of human transthyretin complexed with thyroxine at 2.0 A resolution and 3',5'-dinitro-N-acetyl-L-thyronine at 2.2 A resolutionA Wojtczak, V Cody, J R Luft, et al.
The Journal of Biological Chemistry|September 5, 1986
Inhibition of rat liver iodothyronine deiodinase. Interaction of aurones with the iodothyronine ligand-binding siteM Auf'mkolk, J Koehrle, R D Hesch, et al.
Progress in Clinical and Biological Research|January 1, 1986
Structure-activity relationships of flavonoid deiodinase inhibitors and enzyme active-site modelsV Cody, J Koehrle, M Auf'mkolk, et al.
Anti-Cancer Drug Design|October 1, 1993
Structural and conformational studies on bio-active flavonoids. Crystal and molecular structure of a complex formed between 2',6'-dimethoxyflavone and orthophosphoric acid: a model for flavone-nucleotide interactionsJ C Wallet, V Cody, A Wojtczak, et al.
Antimicrobial Agents and Chemotherapy|August 15, 2001
Isolation of rat dihydrofolate reductase gene and characterization of recombinant enzymeY Wang, J A Bruenn, S F Queener, et al.
Journal of Medicinal Chemistry|December 1, 1977
Molecular structure of thyroxine analogues. Crystal structure of 3,5,3'-triiodothyroacetic and 3,5,3',5'-tetraoiodothyroacetic acid N-diethanolamine (1:1) complexesV Cody, J Hazel, D A Langs, et al.
Drug Design and Discovery|August 1, 1995
Dopaminergic (4aR,10bS)-cis- and (4aS,10bS)-trans-octahydrobenzo[F]quinolines have similar pharmacophoresM Froimowitz, Y Deng, J N Jacob, et al.
Journal of Sports Science & Medicine|April 30, 2014
The physiological responses of chronic heart failure patients to maximal strength test and a balke incremental testItamar Levinger, Roger Bronks, David V Cody, et al.
Pageof 12